Subject Areas :

لیدا عبدالمحمدی خیاو ¹ (بخش تولید واکسن‌های باکتریایی بیهوازی، موسسه واکسن و سرم‌سازی رازی، سازمان تحقیقات آموزش و ترویج کشاورزی، کرج)
احمد رضا جباری ² (بخش تولید واکسن‌های باکتریایی بیهوازی، موسسه واکسن و سرم‌سازی رازی، سازمان تحقیقات آموزش و ترویج کشاورزی، کرج)
رضا پیله چیان لنگرودی ³ (بخش تولید واکسن‌های باکتریایی بیهوازی، موسسه واکسن و سرم‌سازی رازی، سازمان تحقیقات آموزش و ترویج کشاورزی، کرج)

Received: 2015-01-07 Accepted : 2017-11-15 Published : 2018-08-23

Keywords: PCR, کلستریدیوم پرفرینجنز, MLD, Potency, واکسن تتراوالان,

References:

1-Ahsani, M. R. , Shamsaddini, B. M.  (2013). Compare of two methods of direct PCR and PCR with DNA extraction in Clostridium perfringens typing. Scientific-Research Iranian Veterinary Journal 8: 5-12.

 2-Ardehali, M. (1969). Some observations on Clostridium perfringensstrains isolated in Iran..Archives of Razi Institute21: 60 – 66.

 

3-Ardehali, M., Darakhshan, H. (1976). Production and standardization of Clostridium perfringens polyvalent vaccine in Iran.Developmental Biology32: 31-34

  4-ARDEHALI, M., DARAKHSHAN, H.,MOOSAWI, M. (1984). THE EXISTENCE AND PRESENT SITUATION

OF CLOSTRIDIAL DISEASES OF DOMESTIC ANIMALS IN IRAN. ARCHIVES OF RAZI INSTITUTE 34: 27.

   5- Ardehali, M., Moosawi, M., Pilehchian, R. (1994). Isolation of toxigenic strains of Clostridium perfringens     from the soil of farms in Iran. Archives of Razi Institute44,45: 95-100.                                                           

6-Baums, C. G., Schotte, U., Amtsberg, G., Goethe, R. (2004). Diagnostic multiplex PCR for toxin genotyping of Clostridium perfringens isolates. Veterinary Microbiology100:11-16                                                                                                                                                                                                       

7-European Pharmacopoeia. Clostridium perfringens for veterinary use.2005.5^thedition.1 :744-747.                      

 8-European Pharmacopoeia. Clostridium perfringens Vaccines for Veterinary use. 2008: 363.                                      

9-Ghazi, F., Younan, M., Ardehali, M., Muller,W. (1997). Differentiation of proteinase (minor toxin lambda) in Clostridium perfringens strains from sheep and goats in Iran. Deutsche TierarztlicheWochenschrift104: 443-445
10-Jabbari, A.R., Afshari Far, S., Esmaelizad, M., PilehchianLangroudi, R., MoosawiShooshtari, M.,                     AbdolmohammadiKhiav, L. (2011). Molecular typing of toxigenic Clostridium perfringens isolated from sheep in Iran. Archives of RaziInstitute66: 81-86 .

  11- Jansen, B.C., Clark, R., Louw, J.G., De Kock, V.E., Alexander, R.A. (1961). The beta  toxin of Clostridium welchii type B, Wilsdon, in relation to the production of a vaccine against lamb dysentery.Onderstepoort. Journal of Veterinary Research28: 495-549.

 

 12-Kaveh, M. (1957). Journal of Veterinary Medicine 3: 1-8.                                                                                                                                                                            

13-Nijland, R., Lindner, C., Hartskamp, M., Hamoen, L.W., Kuipers, O.P. (2007). Heterologous production and secretion of Clostridium perfringens beta- toxoid in closely related Gram-positive hosts. Journal of                    Biotechnology127: 361-372.                                                                                                                                                                                                                                                              

14-Nillo, L. (1980). Clostridium perfringens in animal disease: A review of current knowledge. The Canadian Veterinary Journal21:141-148.                                                                                                                                                                                                                                          

15- PilehchianLangroudi, R., Aghaei Pour, K., Shamsara, M., Ghorashi, S.A. (2012). In silico fusion of epsilon and beta toxin genes of Clostridium perfringens types D and B. Iranian Journal of Biotechnology10: 54-60.
16-Pilehchian Langroudi, R., Aghaei Pour, K., Shamsara, M., Jabbari, A.R., Habibi, G.R., Goudarzi, H., et al. (2011). Fusion of Clostridium perfringens type D and B epsilon and beta toxin genes and it^,s cloning in E.coli. Archives of RaziInstitute66:1-10.                                                                                                                                                                                                                                     

17-Rafyi, A., Ardehali.M. (1961). Diseases of animals caused by Clostridium welchii. Bulletin - Office               International Des Epizooties 55: 5-6.                                                                                                                                                                   

 18-Rood, JI., Cole, ST. (1991). Molecular genetics and pathogenesis of Clostridium perfringens. Microbiological reviews 55:621-648.                                                                                                                                                                                                                                                                                  

19-Songer, J. G., Meer, R. R. (1996). Genotyping of Clostridium perfringensby polymerase chain reaction is a useful adjunct to diagnosis ofClostridial enteric disease in animals.Anaerobe2: 197-203                                  

20-Sterne, M., Batty, I. (1975). PathogenicClostridia.Butterworth&Co.London.                                                                          

21-Tavakoli, HR., Razavilar,V. (2003). Isolation of Clostridium botiulinum (Types A, B, E) in sediments from Coastal Areas in the North of Iran. Iranian Journal of Public Health 32: 37-40.